Results 261 to 270 of about 119,989 (312)

Molecular theranostics: principles, challenges and controversies

Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 156-164, March 2025.
Molecular theranostics offers a powerful tool to drive precision medicine in nuclear oncology. While theranostics is not a new principle in nuclear medicine, recent advances in instrumentation and radiopharmacy have driven a reinvigoration and a broader suite of applications.
Geoffrey Currie
wiley   +1 more source

Complete metabolic response as early predictor of long-term efficacy after adoptive T cell therapy using tumor-infiltrating lymphocytes. [PDF]

J Immunother Cancer
Borch TH, Andersen R, Hendel HW, Madsen K, Ellebaek E, Marie Svane I.   +5 more
europepmc   +1 more source

Trends in Immunotherapy (IO) Use and Survival Among Patients With High‐Incidence Stage IV Cancers Across the United States

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives IO has transformed cancer management, but its adoption in advanced cancer patients varies by tumor type. With more Stage IV patients undergoing surgery, understanding site‐specific outcomes in these challenging patients is essential.
Samantha C. Warwar, Lauren M. Janczewski, Gladys M. Rodriguez, Jeffrey D. Wayne, David J. Bentrem   +4 more
wiley   +1 more source

Novel research model for in vitro immunotherapy: co-culturing tumor organoids with peripheral blood mononuclear cells. [PDF]

Cancer Cell Int
Li P, Huang M, Ma Y, Zhang Y, Shi C.
europepmc   +1 more source

CT Scans Understage Lymph Nodes in Gastric and Gastroesophageal Adenocarcinoma

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives The presence of lymph node metastases in patients with gastric and gastroesophageal junction (GEJ) adenocarcinoma provides prognostic information and guides treatment decisions. We sought to determine the sensitivity of computed tomography (CT) imaging for clinical nodal staging in patients with resectable gastric and
Morgan F. Pettigrew, Priya Kumar, Skylar L. Nahi, Scott I. Reznik, Suntrea T. G. Hammer, Matthew R. Porembka, Sam C. Wang   +6 more
wiley   +1 more source

Immunotherapy in nasopharyngeal carcinoma: current status and unanswered questions. [PDF]

Lancet Reg Health West Pac
Liu X, Ma J.
europepmc   +1 more source

Evaluating Cost‐Effective Strategies for Asymptomatic Microhematuria Diagnosis: A Risk‐Based Alternative to the American Urological Association Guidelines

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives The American Urological Association (AUA) guidelines recommend evaluating asymptomatic microhematuria (MH) at ≥ 3 red blood cells per high powered field (RBCs/hpf), resulting in significant costs with limited bladder cancer detections.
Krishay Sridalla, Hiten D. Patel, Dustin D. French, Joshua J. Meeks, Lili Zhao, Yuying Xing, David J. Bentrem   +6 more
wiley   +1 more source

Differential regulation of calcium-NFAT signaling pathway by Akt isoforms: unraveling effector dynamics and exhaustion of cytotoxic T lymphocytes in tumor microenvironment. [PDF]

J Immunother Cancer
Chen WL, Chang YL, Lin SF, Protzer U, Isogawa M, Yang HC, Huang LR.   +6 more
europepmc   +1 more source

Immune cell infiltration into brain tumor microenvironment is mediated by Rab27-regulated vascular wall integrity. [PDF]

Sci Adv
Adnani L, Meehan B, Kim M, Choi D, Rudd CE, Riazalhosseini Y, Rak J.   +6 more
europepmc   +1 more source

HPV-driven cancers: a looming threat and the potential of CRISPR/Cas9 for targeted therapy. [PDF]

Virol J
Kermanshahi AZ, Ebrahimi F, Taherpoor A, Eslami N, Baghi HB.   +4 more
europepmc   +1 more source